Prostate specific antigen (PSA) and human kallikrein 2 (hK2) are closely re
lated serine proteases localized primarily in the prostate gland. Despite t
he molecular similarities of the two prostate kallikreins, recent studies h
ave revealed striking differences between hK2 and PSA, Unlike the weak chym
otrypsin-like activity exhibited by PSA, hK2 is a potent trypsin-like enzym
e with more than 20,000-fold relative higher enzyme activity than PSA on pe
ptide substrates, The inactive precursor form of PSA, proPSA, is converted
efficiently to active PSA by hK2 suggesting an important in vivo regulatory
role for hK2 on PSA activity. The high homology between hK2 and PSA result
s in significant cross-reactivity to hK2 by polyclonal and some monoclonal
antibodies to PSA, Monoclonal antibodies specific to hK2 with minimal cross
-reactivity to PSA have been produced, allowing cell and serum analysis of
hK2, Although the same secretory epithelial cells in the prostate produce b
oth kallikreins, hK2 is more highly expressed in poorly differentiated canc
er cells and is more tumor associated than PSA, Preliminary serum studies w
ith immunoassays specific for hK2 indicate that serum hK2 in combination wi
th total and free PSA provides increased specificity for prostate cancer.